|
|
|
|
|
1
|
Regenerative Medicines: Bone and Joint Applications |
Oct 2009 |
$4,850.00 |
|
REPORT HIGHLIGHTS
Overall sales in the regenerative medicine productsmarket were worth $1.1 billion in 2007, and remained flat into 2009. By 2014, sales are projected to increase to nearly $1.8 billion, for a
more...
Published by: BCC Research
| Search inside this report |

|
|
2
|
Stem Cell Markets |
Jun 2009 |
$3,400.00 |
|
A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells
more...
Published by: Trimark Publications
|

|
|
4
|
Growth Factors (Blood And Tissue) |
Oct 2008 |
$3,950.00 |
|
This report analyzes the worldwide markets for Growth Factors (Blood And Tissue) in Millions of US$. The major product segments analyzed are Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins), and Tissue Growth
more...
Published by: Global Industry Analysts
|

|
|
5
|
Advances in Replacement Organs and Tissue Engineering (Technical Insights) |
Sep 2008 |
$6,500.00 |
|
Shortage of Replacement Organs Opens up Opportunities for Tissue Engineering Technology
Over the last decade, tissue engineering has stepped out of the realm of science fiction, into research labs and hospitals all over the
more...
Published by: Frost & Sullivan
|

|
|
6
|
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development |
Mar 2008 |
$3,995.00 |
|
With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers
more...
Published by: Kalorama Information
| Search inside this report |

|
|
7
|
Tissue Engineering and Cell Transplantation: Technologies, Opportunities, and Evolving Markets in the U.S. |
Jul 2007 |
$4,750.00 |
|
Due to the large number of potential patients targeted by tissue engineering and organ regeneration products, and the major healthcare costs associated with existing treatments for these patients, the potential dollar volume for tissue engineering
more...
Published by: Medtech Insight
| Search inside this report |

|
|
8
|
Stem Cell - Analysis and Market Forecasts, 2006-2016 |
Mar 2007 |
$2,995.00 |
|
Sales of stem cell products in the United States reached $16.4 million in 2006 and are expected to surpass $35 million in 2007, according to author Robin R. Young, a medical industry analyst who has
more...
Published by: RRY Publications
|

|
|
9
|
Tissue Engineering & Stem Cell Technology Report 2007 |
Feb 2007 |
$2,210.00 |
|
The market potential of this technology is so huge that revenues may be in excess of $10 billion by 2013. This is a market that you should be part of - NOW!! With a
more...
Published by: Visiongain
|

|
|
10
|
Hitting the Bull's-Eye with Your Eyes Closed: The Stem Cell Magic Bullet |
Dec 2006 |
$500.00 |
|
This Health Industry Insights Perspective describes analyst perspectives on emerging efforts to develop stem cells as therapeutic solutions. Despite only nascent understanding of stem cells and how they work, research is advancing in several
more...
Published by: IDC
| Search inside this report |

|
|
11
|
New Options for Treating Neurological Disease: Stem Cell Therapy |
Dec 2006 |
$1,112.50 |
|
Stem cell therapy development is challenged by controversy, intellectual property issues, and a
high failure rate. Despite these challenges, stem cell therapy presents some of the most promising
options for hard-to-treat and highly degenerative neurological
more...
Published by: Decision Resources
|

|
|
12
|
European Markets for Advanced Wound Management |
Oct 2006 |
$6,500.00 |
|
Research Overview
This Frost & Sullivan research service titled European Markets for Advanced Wound Management provides an analysis of wound dressings and therapies that fall into the category of advanced wound management products. This
more...
Published by: Frost & Sullivan
|

|
|
13
|
Impact of Nano Materials in Drug Delivery & Human Tissue Engineering |
Oct 2006 |
$4,950.00 |
|
D&MD’s new market analysis report - Impact of Nano Materials in Drug Delivery & Human Tissue Engineering - provides a market driven top down approach that identifies existing products using nano based knowledge to strengthen
more...
Published by: Drug and Market Development Publishing
| Search inside this report |

|
|
14
|
Commercial Insight: Transplantation |
Jun 2006 |
$15,200.00 |
|
Introduction
In 2005, over 50.000 solid organ transplants were conducted in the seven major markets. In order to prevent the patient's immune system from rejecting the transplanted organ, immunosuppression therapy is required for the lifetime
more...
Published by: Datamonitor
| Search inside this report |

|
|
15
|
Opportunities in Stem Cell Research and Commercialization: Technology Advances, Regulatory Impact and Key Players |
Mar 2006 |
$2,875.00 |
|
Stem cell transplants are routinely used to treat patients with cancers and other disorders of the blood and the immune system and may hold the key to repairing or replacing tissue cells damaged in many
more...
Published by: Business Insights
|

|
|
16
|
Current Clinical Applications and Trials of Stem Cell - Based Therapies |
Jan 2006 |
$6,500.00 |
|
Ethical Concerns Posing Challenges to the Development of Stem Cell Research Despite their potential to address several unmet medical conditions such as neurodegenerative diseases and cancer, ethical social as well as legal issues are
more...
Published by: Frost & Sullivan
|

|
|
17
|
The Market for Organ and Tissue Transplantation and Alternatives |
Oct 2005 |
$4,543.00 |
|
Organ failure and tissue loss account for half the medical spending in the U.S. In theory, transplantation is the last therapeutic option available to people in the final stage of an organ or tissue failure.
more...
Published by: BCC Research
| Search inside this report |

|
|
18
|
Synthetic Blood Substitutes and Blood Products: A Market Briefing |
Jun 2005 |
$995.00 |
|
In addition to being one of the most important tissues in the body, blood has emerged as a key vector in the transmission of the world's deadliest infectious diseases. With the rising demand for transfusions
more...
Published by: Kalorama Information
| Search inside this report |

|
|
19
|
Tissue Engineering: Technology, Trends, and Market Opportunities |
Sep 2004 |
$4,950.00 |
|
This Report provides an up-to-date, comprehensive analysis of the tissue engineering industry. The Report presents an analysis of core tissue engineering technology (cells, materials, and manufacturing) and evaluates both the technical and market challenges and
more...
Published by: Drug and Market Development Publishing
| Search inside this report |

|
|
20
|
Strategic Analysis of the European Bone Graft Substitutes Market |
Jul 2004 |
$4,995.00 |
|
Clinically Effective Procedures Replace Conventional Methods of Bone Replacement
Bone graft substitutes are quickly replacing autograft bones as the accepted standard for the treatment of musculoskeletal defects. The procedure significantly reduces the time
more...
Published by: Frost & Sullivan
|

|
|
21
|
Stem Cells--Emerging Markets and Growth Opportunities (Technical Insights) |
May 2004 |
$4,550.00 |
|
Regenerative therapies such as stem cell manipulation are developing treatment procedures for damaged tissues and organ failures. The unique ability of stem cells to divide indefinitely and differentiate into specific cell types allows them to
more...
Published by: Frost & Sullivan
|

|
|
22
|
Tissue Engineering-Technology Developments Spur Healthcare Markets |
Dec 2003 |
$4,550.00 |
|
Tissue Engineering and Regenerative Medicine Radically Modify Healthcare Standards
Radical advancements in technologies such as stem cell manipulation and three-dimensional organ printing are enabling the production of living tissues and regenerative therapies. Stem
more...
Published by: Frost & Sullivan
|

|
|
23
|
Opportunities in Stem Cell Technology |
Feb 2002 |
$2,625.00 |
|
In the nascent, but rapidly growing field of stem cell therapies, products are a long way from being commercialized. However, the market potential for stem cell therapies products is very large. This report aims to
more...
Published by: Kalorama Information
| Search inside this report |

|
|
24
|
U.S. Tissue Engineering Markets |
Sep 2001 |
$3,450.00 |
|
Less Invasive Treatments Spurs Tissue Engineering Markets
Approximately eight million surgical procedures are performed annually in the U.S. to treat tissue damage resulting from accidents, birth defects, hereditary
disorders, and other diseases. Because traditional tissue
more...
Published by: Frost & Sullivan
|

|
|
25
|
Emerging Technologies and Opportunities in Structural Tissue Engineering |
Aug 2001 |
$2,437.00 |
|
Few areas of study and development receive as much attention in both the scientific and lay press as Tissue Engineering. This comprehensive report from Kalorama Information examines current products (including features and benefits) and products
more...
Published by: Kalorama Information
| Search inside this report |

|
|
|
|
|